Company Profile
Updated: 17-SEP-09Metrigenix Inc.
Private Subsidiary, Headquarters Location
1450 S Rolling Rd., Baltimore, MD 21227-3863, United States
(443)543-5600, (443)543-5650 fax, http://www.metrigenix.com
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Services: Integrated genomics-based information products, services and bioinformatics.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Ore Pharmaceuticals Announces Its Continuing Transformation into a Drug Development Company - Third Quarter 2008 Financial Results Reported.(Financial report)
Business Wire; 10/31/2008; 1856 words; GAITHERSBURG, Md. -- Ore Pharmaceuticals Inc. (NASDAQ:ORXE) today reported financial results for the...of its long-term investment in Xceed Molecular, formerly MetriGenix, which Ore spun-off in 2001 to allow the further development...
What Big Pharma Company Used PCR to Become One of the Most Powerful Leaders in the Field of Molecular Diagnostics?
Business Wire; 4/4/2007; 1089 words; ...c53391) has announced the addition of the Decision Resources, Inc., report: Recent Advances in the Fast-Growing Molecular...University - School of Medicine - Johnson & Johnson -- MetriGenix -- Nanogen -- Nanolink - Oncomethylome Sciences - Orion Genomics...
Annual Market Forecasts for the Biochips Industry to 2010.
M2 Presswire; 10/19/2006; 1154 words; ...Inc (USA) - GenTel Biosurfaces, Inc (USA) - Greiner Bio-One GmbH...Science Department (USA) - Illumina, Inc (USA) - Infineon Technologies AG...MDS Pharma Services (USA) - Metrigenix, Inc (USA) - Micronit Microfluidics...
Global Biochip Market Set to Grow to about $5.1 Billion in 2009 With a CAGR of 20.2%.
Business Wire; 3/10/2006; 780 words; ...Fluidigm Corporation - Nanogen, Inc. - Nanostream, Inc. - Affymetrix, Inc. - CombiMatrix Corp (Subsidiary of Acacia Research...GE Healthcare Bio-Sciences (Fmr. Amersham) - MetriGenix, Inc. - Mitsubishi Rayon Co., Ltd.(Genomic Device...
Total Biochip Market is Forecast to Grow to about $5.1 billion in 2009 with a CAGR of 20.2%.
M2 Presswire; 3/9/2006; 824 words; ...Fluidigm Corporation- Nanogen, Inc.- Nanostream, Inc.- Affymetrix, Inc.- CombiMatrix Corp (Subsidiary of Acacia Research...GE Healthcare Bio-Sciences (Fmr. Amersham)- MetriGenix, Inc.- Mitsubishi Rayon Co., Ltd.(Genomic Device...
Recent News Articles
- MetriGenix, Inc. and Temple University to Co-Develop Proteomic Chips for Cardiovascular Disease.
Business Wire - April 03, 2002
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning